Monocyte tissue factor levels in cancer patients

Saudi Medical Journal

Volumn 21, Issue 8, 2000, Pages 722-729

  Lwaleed, Bashir A ^a,c   Francis, John L ^b   Chisholm, Morag ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b Hemostatis and Thromb Research Unit   (United States)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Coagulation activation; Monocyte tissue factor; Solid tumors

Indexed keywords

THROMBOPLASTIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER DISEASE; BLADDER TUMOR; BLOOD; BREAST DISEASE; BREAST TUMOR; CASE CONTROL STUDY; COLON DISEASE; COLORECTAL TUMOR; COMPARATIVE STUDY; DISCRIMINANT ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; PROSTATE DISEASE; PROSTATE TUMOR; RISK FACTOR; SECRETION; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLONIC DISEASES; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MONOCYTES; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; THROMBOPLASTIN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER DISEASES; URINARY BLADDER NEOPLASMS;

EID: 0034252924     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Guha A, Bach RR, Konigsberg W, Nemerson Y. Affinity purification of human tissue factor. Interaction of factor VII and tissue factor in detergents micelles. Proc Natl Acad Sci USA 1986; 83: 299-302.
2. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Haemost 1992; 29: 170-176.
3. Maynard JR, Heckman CA, Pitlick EA, Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest 1975; 55: 814-824.
4. Wilcox JN, Smith KM, Schwartz SM, Gorden D. Localization of tissue factor in the normal blood vessel wall and in the atherosclerotic plaque. Proc Nalt Acad Sci USA 1989; 86: 2839-2843.
5. Maynard JR, Dreyer BA, Stemerman MB, Pitlick FA. Tissue factor coagulation activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 1977; 50: 387-396.
6. Drake TA, Morrissey JH, Edgington TA. Selective cellular expression of tissue factor in human tissues: Implication for disorders of haemostasis and thrombosis. Am J Pathol 1989; 134: 1087-1097.
7. Nawroth PP, Stern DM. Modulation of endothelial cell haemostatic properties by tumour necrosis factor. J Exp Med 1986; 163: 740-745.
8. Osterud B, Flaegstad T. Increased thromboplastin activity in monocytes of patients with meningococcal infection. Related to an unfavourable prognosis. Thromh Haemost 1983; 49: 5-7.
9. Dasmahapatra KS, Cheung NK, Spillert C, Lazaro E. An assessment of monocytes procoagulant activity in patients with solid tumours. J Surg Res 1987; 43: 158-163.
10. Contrino J, Hair G, Kreutzer D, Rickles FR. In situ detection of expression of tissue factor in vascular endothehal cells: Correlation with the malignant phenotype of human breast tissue. Nature Med 1996; 2: 209-215.
11. Mellor H, Taylor I, Roath S, Francis JL. Whole blood procoagulant activity in breast and colorectal cancer. J Clin Pathol 1989; 42: 489-494.
12. Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, et al. Activation of blood coagulation in Crohn's disease: Increased fibrinopeptide A levels and enhanced generation of monocytes tissue factor activity. Gastroenterol 1987; 92: 329-337.
13. Osterud B, Due J Jr. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol 1984; 32: 258-264.
14. Muller AD, van Dam-Mieras MCE, Hemker HC. Measurement of macrophage cellular procoagulant activity. Haemostasis 1985; 15: 108-113.
15. Carvalho MG. Monocyte tissue factor in malignancy. [PhD thesis]. Southampton (UK): Southampton University; 1995.
16. Mostofi FK, Sobin LH, Torloni H. WHO international histological classification of tumours-No. 10 Geneva: World Health Organization; 1973.
17. Gleason DF, Mellinger GT. Veterans Administration Cooperative Urological Research Groups: Prediction of prognosis for prostatic adenocarcinoma by combining histological grading and clinical staging. J Urol 1974; 111: 58-64.
18. World Health Organization histological typing of breast tumours. 2nd ed. Am J Clin Pathol 1982; 78: 806-816.
19. Dukes CE. The classification of cancer of the rectum. J Path Bact 1932; 35: 323-332.
20. Carson SD, Konisberg WH. Cadmium increases tissue factor (coagulation factor III) activity by facilitating its reassociation with lipids. Science 1980; 208: 307-309.
21. Campbell MJ, Machin D. Medical statistics: Commonsense approach. 2nd ed. Chichester: John Wiley & Sons; 1993.
22. McKillop JH, Fogelman I. Clinician's guide to nuclear medicine. Benign and malignant disease. London: Churchill Livingstone; 1991. p. 2-9.
23. McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. New Engl J Med 1975; 293: 211-215.
24. Hulka BS. Cancer screening. Degrees of proof and practical application. Cancer. 1988; 62: 1776-1780.
25. Sharfi ARA, El-Sir S, Beleil O. Squamous cell carcinoma of the urinary bladder. Br J Urol 1992; 69: 369-371.
26. Nemerson Y, Gentry R. An ordered addition, essential activation of model of the tissue factor pathway of coagulation: Evidence for conformational change. Biochemistry 1986; 25: 4020-4033.
27. Vassali JD, Dayer JM, Wohlwend A, Belin D. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes macrophages. J Exp Med 1984; 159: 1653-1668.
28. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 62: 14-31.
29. Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, et al The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996; 75: 87-95.
30. Francis JL, Carvalho M, Francis DA. The clinical value of tissue factor assays. Blood Coag Fibrinol 1995; 6: 37-44.
31. Naschitz JE, Yeshurun D, Eldar S, Lev LM. Diagnosis of cancer-associated vascular disorders. Cancer 1996; 77: 1759-1767.
32. Mufti GR, Singh M. Value of random mucosal biopsies in the management of superficial bladder cancer. Eur Urol 1992; 22: 288-293.